Related Experiment Video
Updated: Jul 4, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A
Sebastian P A Rosser1,2, Xuanlin Liu2, Sophie Stocker3,4,5,6,7
1Department of Newborn Screening, Royal Alexandra Hospital for Children, Sydney, NSW, Australia.
Background:
Population pharmacokinetic (popPK) models are increasingly used to support model-informed precision dosing owing to their abilities to account for variability in drug exposure. However, there is no accepted/validated risk of bias (RoB) framework tailored to systematic reviews that externally evaluate popPK models. Therefore, this study was conducted to explore how existing systematic reviews on popPK assess model quality and bias and appraise RoB.
Methods:
A systematic review was conducted in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Systematic reviews that externally evaluated popPK models quantitatively and reported bias/accuracy metrics were searched for on Embase, MEDLINE, PubMed, Web of Science, Cochrane Library, Google Scholar, and CINAHL from inception to November 2025. Data on study selection, external datasets, and model evaluation metrics were extracted. RoB was assessed with RoB in systematic reviews (ROBIS).
Results:
Twenty-two systematic reviews were included. Considerable variation existed in study selection approaches, external validation datasets, and bias assessment metrics. Prediction error-based metrics were most frequently reported ( n = 21), followed by Bayesian forecasting and simulation-based diagnostics (both n = 14). ROBIS assessment indicated recurrent concerns regarding the identification/selection of studies and collection/appraisal of data. Common sources of bias were limitations of external datasets ( n = 19; retrospective design, sparse sampling, small sample size), heterogeneity in bioanalytical methods ( n = 8), and unaccounted treatment-related factors such as concomitant medication ( n = 4).
Conclusions:
ROBIS is only partially applicable to systematic reviews on popPK and insufficiently captures external validation-specific issues. An "external validation" domain with signaling questions focused on dataset provenance, adequacy, and assay consistency is proposed for improving transparency, reproducibility, and comparability across future systematic reviews on popPK.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Overview of Compartment Models
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...